Description: Discussion of solvency problems and the actuary's role in addressing them in the life insurance industry.

Description: A discussion of the role and responsibilities of actuaries beyond crunching numbers

Description: Discussion as to whether within an organization an actuary's regulatory role can conflict with his business-oriented role or be aligned with the strategic goals of the company.

Description: This article discusses HIPAA, Health Insurance Portability and Accountability Act of 1997 and the many NAIC model laws affecting health insurance and paricularly how Arkansas is facing the post-HIPAA complexities.

Description: Views of several actuarial participants in this lawsuit, regarding new buyer disclosure requirements, were printed in our May Issue. Mr. Murphy spoke for the plaintiffs, whose strongest objection to the disputed Wisconsin Regulation was its omission of the Equivalent Level Annual Dividend from the preliminary policy summary.

Description: This article discusses new developments on the regulatory front. Under the new agreement, insurance company management and boards will be required to issue a statement that reflects their judgment about the firm’s viability, including its capital adequacy. The required opinion will have five elements - identifying risks, measuring risks, a risk feedback loop, a risk tolerance statement, and a risk policy.

Description: Discusses features and actuarial aspects of the Truth in Lending Act.

Description: The following commentary, after highlighting the strong linkage that currently exists between valuation reserves and nonforfeiture value requirements, discusses the origins of this relationship. It is concluded that this linkage is undesirable and should be severed. Editor’s Note: This report was prepared for use by the Committee on Non-forfeiture Values. Mr. Gardner is Vice Chairman of the Committee.

Description: On Dec. 29, 1973 President Nixon signed into law the Health Maintenance Organization Act of 1973, which authorizes $375 million to be used by the DHEW to stimulate the establishment and development of HMO's over the next five years. This article describes the status of the regulations and the development of additional HMO's.

Description: This article describes some implications of increasing government intervention in the industry, such as the potential to eliminate the industry's ability to classify risk due to anti-discrimination laws and pressure to expand social 'insurance' programs